Skip to main content
. 2015 Feb 5;9(4):1215–1222. doi: 10.3892/etm.2015.2264

Figure 4.

Figure 4

The mean number of CD314+ cells expressed in the experimental (rituximab) group was higher than that in the control group (p<0.05). No difference was identified between the mean number of CD4+CD25+ cells expressed in the experimental (5.16±1.68%) and control groups (5.19±1.43%) (P>0.05). CD314+ cells expressed in the (A) experimental (23.49±4.22%) and (B) control groups (12.35±2.94%) on day 14; (C) the mean percentages of CD4+CD25+ and CD314+ cells. FITC, fluorescein isothiocyanate.